News

Stunning All-Electric Nest House Listed for $5 Million

Stunning All-Electric Nest House Listed for $5 Million

Introducing the Luxurious Nest House

The Nest House is an architectural marvel now available for $5 million. Nestled in the Berkeley Hills, this all-electric residence is an exciting opportunity for prospective homeowners looking for sustainability and elegance. Designed by the talented duo, Artifact Collaborative, this house marries modern convenience with environmental responsibility.

Design Excellence in Every Detail

With a focus on sustainability, the Nest House boasts features like a passive solar thermal design to enhance its connection to nature. Encompassing 3,583 square feet, this beautiful home offers five bedrooms and four and a half bathrooms. The meticulous attention to detail is evident not just in aesthetics, but also in construction, ensuring that the home is built to withstand the test of time.

Advanced Sustainable Features

The Nest House equips itself with several advanced features, including a green roof and a heat pump for efficient heating and cooling. Homeowners can also expect a solar photovoltaic system, a 240V electric vehicle charger location, and pre-plumbing for a whole home backup battery system. Notably, it also includes a vehicle-to-home battery setup for smarter energy use.

Architectural Beauty with Functionality

This residence is more than just a living space; it's a reflection of modern luxury intertwined with eco-conscious living. The design portrays a stylish modernist aesthetic while being practical and functional for families. Nest House stands out in a market frequently populated by conventional designs, providing an exceptional living experience.

A Prime Location with Scenic Views

Another highlight of the Nest House is its incredible location. Overlooking the beauty of the surrounding landscape, including views of San Francisco and the Bay, residents will appreciate the tranquil yet inspiring environment, all while being conveniently close to local amenities. Enjoy serene moments in the midst of towering redwood trees, accentuated by a large flat lower yard that is a rarity in the Berkeley Hills.

Living in Harmony with Nature

The Nest House's architecture reflects a deep respect for the environment. The incorporation of innovative design principles showcases its commitment to providing a sustainable living space. The thoughtful planning behind its construction ensures minimal impact on the environment while creating a stunning home.

Personal Touches Meet Modern Living

Leverette, the listing agent, describes the Nest House as a striking blend of new luxury and modernist design, influenced by mid-century styles that have shaped home aesthetics worldwide. This unique character helps create a special sense of home, making Nest House one of a kind in the area.

For more information about this property, interested buyers should reach out to Scott Leverette, who can provide further insights into the home and its many features. The contact number is 510.919.3333, offering an opportunity for potential owners to explore what the Nest House has to offer.

Frequently Asked Questions

What is the price of the Nest House?

The Nest House is currently listed for $5 million.

Who designed the Nest House?

The Nest House was designed by Artifact Collaborative, an esteemed architect duo.

What sustainable features does the Nest House include?

The house includes a green roof, solar PV system, heat pump, and pre-plumbing for backup battery systems.

How large is the Nest House?

The home is 3,583 square feet, featuring five bedrooms and four and a half bathrooms.

What type of views can you enjoy from the Nest House?

The Nest House offers spectacular views of San Francisco and the Bay, surrounded by redwood trees.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Embla Medical hf Reports Strong Q2 2025 Financial Performance

Updated Category News Views 203

Embla Medical hf's Interim Report for Q2 2025 Announcement No. 33/2025 Interim Report Q2 2025 Embla Medical hf has recently published its interim report for the second quarter of 2025, revealing encouraging financial results. The organization remains committed to enhancing mobility solutions through innovative offerings in prosthetics and orthotics. Strong Sales Growth...

Continue Reading
Fly-E Group Faces Important Class Action Deadline for Investors

Updated Category News Views 185

Fly-E Group Update: Important Class Action Deadline Attention investors of Fly-E Group, Inc. If you purchased securities between July 15 and August 14, 2025, this is vital news for you. As we approach a crucial lead plaintiff deadline on November 10, 2025, the time to act is now. Understanding the Class Action The upcoming class action lawsuit revolves around Fly-E's...

Continue Reading
Royal Unibrew Posts Impressive Earnings Growth in Q3 2024

Updated Category News Views 173

Royal Unibrew's Remarkable Performance in Q3 2024 Royal Unibrew has demonstrated exceptional growth during the third quarter of 2024. The key highlights from this trading statement reveal a robust progression in organic volume and net revenue, paving the way for a bright future for the company. Strong Growth Metrics Organic Volume and Revenue Increases During Q3 2024,...

Continue Reading
Examining Medtronic PLC's Short Selling Trends and Insights

Updated Category News Views 184

Understanding Medtronic PLC's Short Interest Medtronic PLC (NYSE: MDT) has recently experienced a significant rise in its short interest as a percentage of float, currently at 17.56%. This increase signals a growing concern among investors, as the total number of shares sold short has reached 19.72 million, accounting for 1.54% of all available shares for trading. With...

Continue Reading
Palatin Technologies Announces Breakthrough in Obesity Management

Updated Category News Views 138

Positive Developments in Appetite Suppression Research Palatin Technologies, Inc. (NYSE American: PTN), a leading biopharmaceutical firm known for pioneering medications based on the melanocortin receptor system, has recently reported encouraging results concerning appetite suppression from its Phase 2 obesity study involving bremelanotide and tirzepatide. This...

Continue Reading